Skip to main content
MedicHelpLine
Join Free
Verified Professional Network190+ CountriesHIPAA-Aware Platform
Back to Drug Index
General MedicationsORALGeneric

TRECATOR

ETHIONAMIDE

Standard Dose
250MG
Max Dose
Refer to approved labeling
Primary Use
Review priority: STANDARD Marketing status: Discontinued
Summary

Approval overview TRECATOR is listed in Drugs@FDA under application 013026 (NDA).

Review priority: STANDARD Marketing status: Discontinued Active ingredient ETHIONAMIDE Form and strength TABLET;ORAL - 250MG Sponsor WYETH PHARMS Submission history Latest submission status date: 2023-08-03 00:00:00.

Structured Monograph

Clinical summary

Approval overview TRECATOR is listed in Drugs@FDA under application 013026 (NDA). Review priority: STANDARD Marketing status: Discontinued Active ingredient ETHIONAMIDE Form and strength TABLET;ORAL - 250MG Sponsor WYETH PHARMS Submission history Latest submission status date: 2023-08-03 00:00:00. Submission type: SUPPL.

Monitoring

  • • Marketing status: Discontinued
  • • Review priority: STANDARD

Interaction Notes

  • No interaction notes stored yet.